Global /China /Healthcare /Drug Manufacturers - General /300401

Zhejiang Garden Biopharmaceutical Co.,Ltd.

300401

• SHE: 300401 • Delayed

13.05CNY -1.2%

1.93 USD

As of 24 June 2026, Zhejiang Garden Biopharmaceutical Co.,Ltd. has a market cap of $1.06B USD, ranking #10401 globally and #2911 in China. It ranks #928 in the Healthcare sector, and #348 in the Drug Manufacturers - General industry.

Global Rank

10401

Country Rank

2911

Sector Rank

928

Industry Rank

348

Key Stats

Market Cap

$1.06BUSD

7.18B CNY

Enterprise Value

$1.07BUSD

7.28B CNY

Revenue (TTM)

$175.34MUSD

1.19B CNY

EBITDA (TTM)

$74.16MUSD

502.01M CNY

Net Income (TTM)

$38.17MUSD

258.62M CNY

EBITDA Margin

42%

Profit Margin

22%

PE Ratio

30.8

Forward PE

16.5

PS Ratio

6.0

PB Ratio

2.0

EV/EBITDA

14.5

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Huanzheng Ma open_in_new

Employees

1,021

Founded

2000

Website

hybiotech.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	-1.5%	-8.4%	-23%	-6.1%	-14%	-13%	3.1%	-2.8%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	300401 浙江花园生物医药股份有限公司 Class A ISIN: CNE100001XX7 Shares Out.: Shares Outstanding: 543.685M¹ Shares Float: 342.793M² TV: TradingView: SZSE: 300401 SA: Stock Analysis: SHE: 300401 YF: Yahoo Finance: 300401.SZ GF: Google Finance: SHE: 300401 BA: Barron's: 300401 MS: Morningstar: XSHE: 300401	13.05 CNY	TV: TradingView: SZSE: 300401 SA: Stock Analysis: SHE: 300401 YF: Yahoo Finance: 300401.SZ GF: Google Finance: SHE: 300401 BA: Barron's: 300401 MS: Morningstar: XSHE: 300401

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Garden Biopharmaceutical Co.,Ltd.

Zhejiang Garden Biopharmaceutical Co.,Ltd. engages in the research, development, production and sales of vitamin products and pharmaceuticals in China. The company offers lanolin cholesterol series products, such as cholesterol and feed grade cholesterol; vitamin D3 products, including food additives compound nutrient fortifier SDS, food additives compound nutritional fortifier CO and MO, cholecalciferol, vitamin D3 particles, feed additive vitamin D3 oil, and VD3 resin oil; and 25 HydroxyVitamin D3 Progen, 25 hydroxyvitamin D3, and 25 hydroxyvitamin D3 powder. It also provides refined lanolin comprising anhydrous lanolin, wool oil, wool wax, low chroma ultra pure fat, lanolin alcohol, isopropyl lanolate, lanolinic acid, high acid fat, and wool acid biofuel/wool alcohol biofuel; and vitamin D3 environmental rodenticide. Zhejiang Garden Biopharmaceutical Co.,Ltd. was formerly known as Zhejiang Garden Bio-chemical High-tech Co., Ltd. and changed its name to Zhejiang Garden Biopharmaceutical Co.,Ltd. in April 2023. Zhejiang Garden Biopharmaceutical Co.,Ltd. was founded in 2000 and is based in Dongyang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.86B 364.89B CNY 5K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.65B 336.36B CNY 5K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.51B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 72K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 52K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 34K%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 30K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 27K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 26K%	15.1	United States

chevron_leftBack